ADAMTS15

ADAM Metallopeptidase with Thrombospondin Type 1 Motif 15

Gene Information Card

Symbol ADAMTS15
Full Name ADAM metallopeptidase with thrombospondin type 1 motif 15
Gene Type protein-coding
Chromosomal Location 11q24.3
NCBI Gene ID 170689 ncbi.nlm.nih.gov/gene/170689
Ensembl ID ENSG00000166106
UniProt ID Q8TE58
OMIM ID 607510
HGNC ID 16300
Aliases ADAMTS15, ADAMTS-15, METH-8

Description

ADAMTS15 encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of zinc-dependent metalloproteinases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which functions in the degradation of proteoglycans such as aggrecan and versican. ADAMTS15 is involved in extracellular matrix remodeling, cell migration, and has been implicated in cancer progression and osteoarthritis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Osteoarthritis ADAMTS15 contributes to aggrecan degradation in articular cartilage, leading to joint degeneration. PMID: 19330029
Colorectal cancer ADAMTS15 expression is downregulated in colorectal tumors; loss of function may promote tumor invasion. PMID: 21947005
Breast cancer ADAMTS15 acts as a tumor suppressor; reduced expression correlates with poor prognosis. PMID: 25695637

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 2.3 Low
Breast 1.8 Low
Colon 3.1 Medium
Kidney 1.5 Low
Liver 0.9 Not detected
Lung 2.0 Low
Ovary 2.5 Low
Prostate 1.2 Low
Skin 1.6 Low
Testis 4.2 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 2.1 Low expression
HT-29 (colorectal cancer) 1.5 Low expression
HEK 293 (embryonic kidney) 3.8 Medium expression
HepG2 (liver cancer) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1276C>T (p.Arg426*) Nonsense <0.1% in COSMIC Loss of function; truncation of catalytic domain
c.1672G>A (p.Gly558Arg) Missense 0.2% in COSMIC Unknown; predicted damaging by SIFT
c.2149_2150insA (p.Thr717Asnfs*12) Frameshift <0.1% in COSMIC Loss of function; premature stop
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg426*, p.Thr717Asnfs*12) result in truncated protein lacking catalytic activity.

Gain of Function (GOF)

No gain-of-function mutations reported in COSMIC or ClinVar.

Dominant Negative (DN)

No dominant-negative mutations described in literature.

Pathways

ECM degradation (Reactome: R-HSA-1474228)
Aggrecan degradation in osteoarthritis (KEGG: hsa05320)

Protein Summary

ADAMTS15 is a secreted metalloproteinase composed of a signal peptide, a prodomain, a catalytic domain with a zinc-binding motif, a disintegrin-like domain, a central thrombospondin type 1 repeat, a cysteine-rich domain, and a spacer region. The enzyme cleaves aggrecan at the Glu373-Ala374 bond and versican at the Glu441-Ala442 bond. Its activity is regulated by tissue inhibitors of metalloproteinases (TIMPs). ADAMTS15 is widely expressed in adult tissues, with highest levels in testis and colon. Reduced expression is observed in several cancers, suggesting a tumor-suppressive role.

Related Products

Product name Cat.No. Species Gene ID
ADAMTS15 Knockout HEK293 Cell Line EDJ-KQ11966 Human 170689 Details Get a Quote
ADAMTS15 Knockout A-549 Cell Line EDJ-KQ40517 Human 170689 Details Get a Quote
ADAMTS15 Knockout HeLa Cell Line EDJ-KQ40518 Human 170689 Details Get a Quote
ADAMTS15 Knockout HCT 116 Cell Line EDJ-KQ75827 Human 170689 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: